G. Bradley Cole, CFO at GENOMIC HEALTH INC (GHDX), sold 16,252 shares at $78.29 ($1.3M) on 2018-11-13, disclosed to the SEC on 2018-11-15.
Seasonal sale ($1.3M) by CFO — this insider has traded GHDX in November in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.29 | 2,817 | $221K | 17.2% |
| 2 | $78.29 | 2,817 | $221K | 17.2% |
| 3 | $78.34 | 1,976 | $155K | 12.0% |
| 4 | $78.34 | 1,976 | $155K | 12.0% |
| 5 | $79.20 | 400 | $32K | 2.5% |
| 6 | $79.20 | 400 |
| $32K |
| 2.5% |
| 7 | $79.30 | 600 | $48K | 3.7% |
| 8 | $79.30 | 600 | $48K | 3.7% |
| 9 | $80.23 | 900 | $72K | 5.6% |
| 10 | $80.32 | 1,083 | $87K | 6.8% |
| 11 | $80.32 | 1,083 | $87K | 6.8% |
| 12 | $81.46 | 300 | $24K | 1.9% |
| 13 | $81.46 | 300 | $24K | 1.9% |
| 14 | $81.60 | 500 | $41K | 3.2% |
| 15 | $81.60 | 500 | $41K | 3.2% |
| Total | $79.12 avg | 16,252 | $1.3M | 100% |
| Filing → |
| EXAS | SELL | 2020-02-21 | $2.7M | — | Filing → |
| EXAS | SELL | 2020-01-17 | $903K | — | Filing → |
| EXAS | SELL | 2019-11-25 | $4.5M | — | Filing → |